(Q37359616)

English

Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias

scientific article published on January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias (English)

1 reference

Europe PubMed Central

19 August 2017

author name string

Kathy M Makkar

1

1 reference

Europe PubMed Central

19 August 2017

Cynthia A Sanoski

2

1 reference

Europe PubMed Central

19 August 2017

Sarah A Spinler

3

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

1 January 2009

1 reference

Europe PubMed Central

19 August 2017

Pharmacotherapy

1 reference

Europe PubMed Central

19 August 2017

29

1 reference

Europe PubMed Central

19 August 2017

1

1 reference

Europe PubMed Central

19 August 2017

31-48

1 reference

Europe PubMed Central

19 August 2017

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Electrical, contractile and structural remodeling during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Angiotensin II modulates the delayed rectifier potassium current of guinea pig ventricular myocytes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

The impact of suppressing the renin-angiotensin system on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.31

21 January 2018

Identifiers

10.1592/PHCO.29.1.31

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37359616&oldid=1702148826"